Ben Finlay is the founder and CEO of Ranvier, a health technology company developing objective diagnostics for depression and neurodegenerative disease. Under his leadership, Ranvier has built a novel platform – led by the TasteDX test – to tackle the global mental health crisis with scalable, clinically proven tools. Ben is driving the company’s expansion across public health, direct-to-consumer, and research channels, with a focus on earlier detection and better long-term care. He brings over 20 years of experience in life sciences innovation, launching high-growth ventures and forging partnerships across pharma, digital health, and health systems. Ben majored in Applied Biology and holds a Master’s in Business Change & Corporate Innovation. His prior commercial success bridges diagnostic science, behavioural health, and personalised care; delivering significant new value to market for large corporate and scale-up entities. Ben is uniquely poised to deliver Ranvier as a next-generation platform for exceptional mind health.